| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
33,350,000 | 34,250,400 | 36,801,400 | 35,460,400 | 33,480,000 |
| Cost of Revenue
|
-25,809,000 | -26,134,200 | -27,266,000 | -26,110,000 | -22,975,900 |
|
Gross Profit
|
7,541,000 | 8,116,200 | 9,535,400 | 9,350,400 | 10,504,100 |
|
Selling, General and Administrative Expenses
|
-3,730,600 | -3,692,000 | -3,599,500 | -3,248,800 | -2,933,700 |
|
Operating Income/Expenses
|
-3,730,600 | -3,692,000 | -3,599,500 | -3,248,800 | -2,933,700 |
|
Total Operating Profit/Loss
|
3,810,400 | 4,424,200 | 5,935,900 | 6,101,600 | 7,570,400 |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
286,000 | 315,700 | 348,800 | 213,100 | 59,300 |
|
Non-Operating Income/Expenses, Total
|
286,000 | 315,700 | 348,800 | 213,100 | 59,300 |
|
Pretax Income
|
4,096,400 | 4,739,900 | 6,284,700 | 6,314,700 | 7,629,700 |
|
Provision for Income Tax
|
-1,001,500 | -1,119,000 | -1,478,700 | -1,519,500 | -1,734,100 |
|
Net Income from Continuing Operations
|
3,094,900 | 3,620,900 | 4,806,000 | 4,795,200 | 5,895,600 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,094,900 | 3,620,900 | 4,806,000 | 4,795,200 | 5,895,600 |
|
Non-Controlling/Minority Interests
|
-42,000 | -35,700 | -49,600 | -49,500 | -38,100 |
|
Net Income after Non-Controlling/Minority Interests
|
3,052,900 | 3,585,200 | 4,756,400 | 4,745,700 | 5,857,500 |
|
Net Income Available to Common Stockholders
|
3,052,900 | 3,585,200 | 4,756,400 | 4,745,700 | 5,857,500 |
|
Diluted Net Income Available to Common Stockholders
|
3,052,900 | 3,585,200 | 4,756,400 | 4,745,700 | 5,857,500 |
|
Common Dividend per Share
|
1.35 | -- | 1.20 | 1.00 | 0.90 |
| Basic EPS
|
10.53 | 11.62 | 14.44 | 13.93 | 16.65 |
| Diluted EPS
|
10.49 | 11.57 | 14.34 | 13.82 | 16.51 |
|
Basic Weighted Average Shares Outstanding
|
289,600 | 308,500 | 329,500 | 340,700 | 351,700 |
|
Diluted Weighted Average Shares Outstanding
|
290,625 | 309,900 | 331,600 | 343,300 | 354,800 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,916,100 | 4,626,500 | 6,202,000 | 6,280,800 | 7,629,700 |
|
EBITDA
|
4,028,300 | 4,727,800 | 6,289,100 | 6,372,400 | 7,711,100 |
|
Normalized EBITDA
|
4,288,200 | 5,016,900 | 6,486,000 | 6,563,900 | 7,886,600 |
|
Normalized Income
|
3,291,258.87 | 3,841,772.40 | 4,956,628.50 | 4,940,548.50 | 6,031,261.50 |
|
Total Unusual Items
|
259,900 | 289,100 | 196,900 | 191,500 | 175,500 |
|
Total Unusual Items Excluding Goodwill
|
259,900 | 289,100 | 196,900 | 191,500 | 175,500 |
|
Tax Effect of Unusual Items
|
63,541.13 | 68,227.60 | 46,271.50 | 46,151.50 | 39,838.50 |
9/30/2022 - 9/8/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade